Literature DB >> 11547948

Dominantly inherited myopathy with novel tubular aggregates containing 1-21 tubulofilamentous structures.

H D Müller1, S Vielhaber, A Brunn, J M Schröder.   

Abstract

Tubular aggregates (TAs) in skeletal muscle fibers have been observed as a nonspecific finding in a number of different conditions such as periodic paralysis, myotonic disorders, hyperaldosteronism, chronic use of drugs, and alcoholism. However, TAs were also found more specifically in well-defined muscle disorders, e.g., exercise-induced cramps, myasthenic syndromes, and even in dominantly or recessively inherited familial myopathies. We report on a presumably dominantly inherited familial myopathy with late onset characterized morphologically by the presence of three types of TAs in type II muscle fibers identified in three affected members of one family (a 86-year-old man and his two sons). The first, novel type was characterized by tubules, 30-200 nm in thickness which included 1-21 tubulofilamentous structures 14-18 nm in diameter. The second type of TAs corresponded to previously well-described tubules and were derived from terminal cisternae, which were rather irregularly arranged or widened, and filled with material of medium electron density. The third type of TAs were occasional, hexagonally arranged TAs of the usual type [type Ib and Ic]. Rare annulate lamellae were also seen. Our findings support the evidence of tubular aggregates as the major finding in certain dominantly inherited myopathies. Tubules of the first type, to the best of our knowledge, have not been recorded in any other myopathy. It is therefore suggested that these tubules characterize a novel type of a benign, slowly progressive myopathy with late onset, muscle pain, cramps, and stiffness.

Entities:  

Mesh:

Year:  2001        PMID: 11547948     DOI: 10.1007/s004010000342

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

1.  Sequential stages in the age-dependent gradual formation and accumulation of tubular aggregates in fast twitch muscle fibers: SERCA and calsequestrin involvement.

Authors:  Simona Boncompagni; Feliciano Protasi; Clara Franzini-Armstrong
Journal:  Age (Dordr)       Date:  2011-02-12

2.  SKELETAL MUSCLE MITOCHONDRIAL ALTERATIONS IN CARBOXYL TERMINUS OF HSC70 INTERACTING PROTEIN (CHIP) -/- MICE.

Authors:  Jonathan C Schisler; Cam Patterson; Monte S Willis
Journal:  Afr J Cell Pathol       Date:  2016-04

3.  Molecular Characterization of Skeletal Muscle Dysfunction in Sigma 1 Receptor (Sigmar1) Knockout Mice.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Naznin S Remex; Shafiul Alam; Mahboob Morshed; Sadia Nitu; Brandon Hartman; Judy King; Mohammad Alfrad Nobel Bhuiyan; A Wayne Orr; Christopher G Kevil; Md Shenuarin Bhuiyan
Journal:  Am J Pathol       Date:  2021-10-25       Impact factor: 4.307

4.  Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy.

Authors:  Johann Böhm; Frédéric Chevessier; André Maues De Paula; Catherine Koch; Shahram Attarian; Claire Feger; Daniel Hantaï; Pascal Laforêt; Karima Ghorab; Jean-Michel Vallat; Michel Fardeau; Dominique Figarella-Branger; Jean Pouget; Norma B Romero; Marc Koch; Claudine Ebel; Nicolas Levy; Martin Krahn; Bruno Eymard; Marc Bartoli; Jocelyn Laporte
Journal:  Am J Hum Genet       Date:  2013-01-17       Impact factor: 11.025

5.  Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy.

Authors:  Gaetano Nicola Alfio Vattemi; Daniela Rossi; Lucia Galli; Maria Rosaria Catallo; Elia Pancheri; Giulia Marchetto; Barbara Cisterna; Manuela Malatesta; Enrico Pierantozzi; Paola Tonin; Vincenzo Sorrentino
Journal:  Eur J Neurosci       Date:  2022-06-13       Impact factor: 3.698

6.  Muscle MR imaging in tubular aggregate myopathy.

Authors:  Valeria Beltrame; Paolo Ortolan; Alessandro Coran; Riccardo Zanato; Matteo Gazzola; Annachiara Frigo; Luca Bello; Elena Pegoraro; Roberto Stramare
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.